Answers are grounded in this paper and cite their sources.
// Xumin Zhou 1, * , Qi Li 4, * , Jincan He 5, * , Liren Zhong 1 , Fangpeng Shu 1 , Rongwei Xing 6 , Daojun Lv 1 , Bin Lei 1 , Bo Wan 1 , Yu Yang 2 , Huayan Wu 1 , Xiangming Mao 1, 2 , Yaguang Zou 3 1 Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, P. R.China 2 Department of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, 518036, P. R.China 3 Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, P. R.China 4 Department of Urology, Maternal and Health Care Hospital, Longgang District, Shenzhen 518036, P. R.China 5 Department of Urology, Fourth Affiliated Hospital, Guangxi Medical University, Liuzhou 545005, P. R.China 6 Department of Urology, Affiliated Weihai Second Municipal Hospital of Qingdao University, Weihai 264200, P. R.China * These authors have contributed equally to this work Correspondence to: Xiangming Mao, email: mxming2014@163.com Yaguang Zou, email: 18620050609@163.com Keywords: prostate cancer, HnRNP-L, proliferation, apoptosis, molecular mechanism Received: August 19, 2016 Accepted: December 01, 2016 Published: December 27, 2016 ABSTRACT Expression of the RNA-binding protein HnRNP-L was previously shown to associate with tumorigenesis in liver and lung cancer. In this study, we examined the role of HnRNP-L in prostate cancer (Pca). We found that HnRNP-L is overexpressed in prostate tissue samples from 160 PC patients compared with tissue samples from 32 donors with cancers other than Pca. Moreover, HnRNP-L positively correlated with aggressive tumor characteristics. HnRNP-L knockdown inhibited cell proliferation and promoted cell apoptosis of Pca cell lines in vitro , and suppressed tumor growth when the cells were subcutaneously implanted in an athymic mouse model. Conversely, overexpression of HnRNP-L promoted cell proliferation and tumor growth while prohibiting cell apoptosis. HnRNP-L promoted cell proliferation and tumor growth in Pca in part by interacting with endogenous p53 mRNA, which was closely associated with cyclin p21. In addition, HnRNP-L affected cell apoptosis by directly binding the classical apoptosis protein BCL-2. These observations suggest HnRNP-L is an important regulatory factor that exerts pro-proliferation and anti-apoptosis effects in Pca through actions affecting the cell cycle and intrinsic apoptotic signaling. Thus HnRNP-L could potentially serve as a valuable molecular biomarker or therapeutic target in the treatment of Pca.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: